These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 22015727)

  • 1. Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers.
    Wetterskog D; Lopez-Garcia MA; Lambros MB; A'Hern R; Geyer FC; Milanezi F; Cabral MC; Natrajan R; Gauthier A; Shiu KK; Orr N; Shousha S; Gatalica Z; Mackay A; Palacios J; Reis-Filho JS; Weigelt B
    J Pathol; 2012 Jan; 226(1):84-96. PubMed ID: 22015727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic landscape of adenoid cystic carcinoma of the breast.
    Martelotto LG; De Filippo MR; Ng CK; Natrajan R; Fuhrmann L; Cyrta J; Piscuoglio S; Wen HC; Lim RS; Shen R; Schultheis AM; Wen YH; Edelweiss M; Mariani O; Stenman G; Chan TA; Colombo PE; Norton L; Vincent-Salomon A; Reis-Filho JS; Weigelt B
    J Pathol; 2015 Oct; 237(2):179-89. PubMed ID: 26095796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type.
    Lacroix-Triki M; Suarez PH; MacKay A; Lambros MB; Natrajan R; Savage K; Geyer FC; Weigelt B; Ashworth A; Reis-Filho JS
    J Pathol; 2010 Nov; 222(3):282-98. PubMed ID: 20815046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotypic and genomic characterization of papillary carcinomas of the breast.
    Duprez R; Wilkerson PM; Lacroix-Triki M; Lambros MB; MacKay A; A'Hern R; Gauthier A; Pawar V; Colombo PE; Daley F; Natrajan R; Ward E; MacGrogan G; Arbion F; Michenet P; Weigelt B; Vincent-Salomon A; Reis-Filho JS
    J Pathol; 2012 Feb; 226(3):427-441. PubMed ID: 22025283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features.
    Schwartz CJ; Brogi E; Marra A; Da Cruz Paula AF; Nanjangud GJ; da Silva EM; Patil S; Shah S; Ventura K; Razavi P; Norton L; D'alfonso T; Weigelt B; Pareja F; Reis-Filho JS; Wen HY
    Mod Pathol; 2022 Feb; 35(2):193-201. PubMed ID: 34599282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene.
    Kim J; Geyer FC; Martelotto LG; Ng CK; Lim RS; Selenica P; Li A; Pareja F; Fusco N; Edelweiss M; Kumar R; Gularte-Merida R; Forbes AN; Khurana E; Mariani O; Badve S; Vincent-Salomon A; Norton L; Reis-Filho JS; Weigelt B
    J Pathol; 2018 Feb; 244(2):143-150. PubMed ID: 29149504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYB Translocation Status in Salivary Gland Epithelial-Myoepithelial Carcinoma: Evaluation of Classic, Variant, and Hybrid Forms.
    Bishop JA; Westra WH
    Am J Surg Pathol; 2018 Mar; 42(3):319-325. PubMed ID: 29135517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoid cystic carcinoma of the Bartholin's gland is underpinned by MYB- and MYBL1- rearrangements.
    Feinberg J; Da Cruz Paula A; da Silva EM; Pareja F; Patel J; Zhu Y; Selenica P; Leitao MM; Abu-Rustum NR; Reis-Filho JS; Joehlin-Price A; Weigelt B
    Gynecol Oncol; 2024 Jun; 185():58-67. PubMed ID: 38368814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer.
    Fusco N; Geyer FC; De Filippo MR; Martelotto LG; Ng CK; Piscuoglio S; Guerini-Rocco E; Schultheis AM; Fuhrmann L; Wang L; Jungbluth AA; Burke KA; Lim RS; Vincent-Salomon A; Bamba M; Moritani S; Badve SS; Ichihara S; Ellis IO; Reis-Filho JS; Weigelt B
    Mod Pathol; 2016 Nov; 29(11):1292-1305. PubMed ID: 27491809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYB RNA In Situ Hybridization Is a Useful Diagnostic Tool to Distinguish Breast Adenoid Cystic Carcinoma From Other Triple-negative Breast Carcinomas.
    Butcher MR; White MJ; Rooper LM; Argani P; Cimino-Mathews A
    Am J Surg Pathol; 2022 Jul; 46(7):878-888. PubMed ID: 35522890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms.
    Brill LB; Kanner WA; Fehr A; Andrén Y; Moskaluk CA; Löning T; Stenman G; Frierson HF
    Mod Pathol; 2011 Sep; 24(9):1169-76. PubMed ID: 21572406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoid cystic carcinoma of the lacrimal gland: MYB gene activation, genomic imbalances, and clinical characteristics.
    von Holstein SL; Fehr A; Persson M; Therkildsen MH; Prause JU; Heegaard S; Stenman G
    Ophthalmology; 2013 Oct; 120(10):2130-8. PubMed ID: 23725736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components.
    Marchiò C; Iravani M; Natrajan R; Lambros MB; Geyer FC; Savage K; Parry S; Tamber N; Fenwick K; Mackay A; Schmitt FC; Bussolati G; Ellis I; Ashworth A; Sapino A; Reis-Filho JS
    J Pathol; 2009 Jul; 218(3):301-15. PubMed ID: 19479727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYB-NFIB gene fusion in adenoid cystic carcinoma of the breast with special focus paid to the solid variant with basaloid features.
    D'Alfonso TM; Mosquera JM; MacDonald TY; Padilla J; Liu YF; Rubin MA; Shin SJ
    Hum Pathol; 2014 Nov; 45(11):2270-80. PubMed ID: 25217885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype?
    Natrajan R; Lambros MB; Geyer FC; Marchio C; Tan DS; Vatcheva R; Shiu KK; Hungermann D; Rodriguez-Pinilla SM; Palacios J; Ashworth A; Buerger H; Reis-Filho JS
    Genes Chromosomes Cancer; 2009 Apr; 48(4):351-65. PubMed ID: 19156836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutations.
    Wetterskog D; Wilkerson PM; Rodrigues DN; Lambros MB; Fritchie K; Andersson MK; Natrajan R; Gauthier A; Di Palma S; Shousha S; Gatalica Z; Töpfer C; Vukovic V; A'Hern R; Weigelt B; Vincent-Salomon A; Stenman G; Rubin BP; Reis-Filho JS
    Histopathology; 2013 Mar; 62(4):543-50. PubMed ID: 23398044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance.
    Mitani Y; Li J; Rao PH; Zhao YJ; Bell D; Lippman SM; Weber RS; Caulin C; El-Naggar AK
    Clin Cancer Res; 2010 Oct; 16(19):4722-31. PubMed ID: 20702610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast.
    Marchiò C; Iravani M; Natrajan R; Lambros MB; Savage K; Tamber N; Fenwick K; Mackay A; Senetta R; Di Palma S; Schmitt FC; Bussolati G; Ellis LO; Ashworth A; Sapino A; Reis-Filho JS
    J Pathol; 2008 Aug; 215(4):398-410. PubMed ID: 18484683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptomic analysis of tubular carcinomas of the breast reveals similarities and differences with molecular subtype-matched ductal and lobular carcinomas.
    Lopez-Garcia MA; Geyer FC; Natrajan R; Kreike B; Mackay A; Grigoriadis A; Reis-Filho JS; Weigelt B
    J Pathol; 2010 Sep; 222(1):64-75. PubMed ID: 20593406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYB Labeling by Immunohistochemistry Is More Sensitive and Specific for Breast Adenoid Cystic Carcinoma than MYB Labeling by FISH.
    Poling JS; Yonescu R; Subhawong AP; Sharma R; Argani P; Ning Y; Cimino-Mathews A
    Am J Surg Pathol; 2017 Jul; 41(7):973-979. PubMed ID: 28498281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.